Magnetic resonance imaging in immune-mediated myelopathies

J Neurol. 2020 May;267(5):1233-1244. doi: 10.1007/s00415-019-09206-2. Epub 2019 Jan 29.

Abstract

Immune-mediated myelopathies are a heterogeneous group of inflammatory spinal cord disorders including autoimmune disorders with known antibodies, e.g. aquaporin-4 IgG channelopathy or anti-myelin oligodendrocyte glycoprotein-associated myelitis, myelopathies in the context of multiple sclerosis and systemic autoimmune disorders with myelopathy, as well as post-infectious and paraneoplastic myelopathies. Although magnetic resonance imaging of the spinal cord is still challenging due to the small dimension of the cord cross-section and frequent movement and susceptibility artifacts, recent methodological advances have led to improved diagnostic evaluation and characterization of immune-mediated myelopathies. Topography, length and width of the lesion, gadolinium enhancement pattern, and changes in morphology over time help in narrowing the broad differential diagnosis. In this review, we give an overview of recent advances in magnetic resonance imaging of immune-mediated myelopathies and its role in the differential diagnosis and monitoring of this heterogeneous group of disorders.

Keywords: Autoimmune myelopathies; Immune-mediated myelopathies; Magnetic resonance imaging; Multiple sclerosis; Myelitis; NMOSD.

Publication types

  • Review

MeSH terms

  • Autoimmune Diseases of the Nervous System / diagnostic imaging*
  • Humans
  • Magnetic Resonance Imaging* / standards
  • Neuroimaging* / standards
  • Spinal Cord Diseases / diagnostic imaging*